Press Releases
Keyword Search
09.06.17
OpGen to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
08.08.17
OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update
08.02.17
OpGen Announces Date of Second Quarter 2017 Financial Results Conference Call
07.19.17
OpGen Announces Closing of $10 Million Public Offering
07.13.17
OpGen Announces Pricing of $10.0 Million Public Offering
07.12.17
OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health
06.19.17
OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test
06.15.17
OpGen’s Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities
06.05.17
OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control
05.30.17
OpGen to Receive Ignaz Semmelweis Award for Commitment to Combatting Infection Deaths